An early study in the postmortem brain tissue of individuals with AD and healthy controls found that there was no difference in CRFBP levels measured between groups, except for a significant decrease in CRFBP observed in Brodmann area (BA) 39 (Behan et al., 1997). Here, CRHBP is linked to Alzheimer disease.